Breaking News

Cytocom to Become Statera BioPharma

New name reflects strategic focus on addressing autoimmune and inflammatory diseases, blood disorders, infectious disease and cancer.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cytocom, Inc., a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, plans to change its name to Statera BioPharma, Inc. effective September 1, 2021. As part of the name change, Statera BioPharma plans to release a new company logo and launch a new company website at www.staterabiopharma.com. The new corporate name, Statera, taken from the Latin word for “balance,” and tagline “Restoring Immune Health” was ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters